BridgeBio Pharma Inc (BBIO) — Free Cash Flow Generation Index
Latest as of June 2024:
0.97x
BridgeBio Pharma Inc (BBIO) has a Free Cash Flow Generation Index of 0.97x as of June 2024. Free cash flow of $72.26 Million represents 1% of operating cash flow ($74.70 Million). Explore BBIO capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.97x
Free Cash Flow / Operating CF
Free Cash Flow
$72.26 Million
USD
Operating Cash Flow
$74.70 Million
USD
Capital Expenditures
$2.45 Million
USD
Annual Free Cash Flow Generation for BridgeBio Pharma Inc (None–None)
Year-by-year Free Cash Flow Generation Index for BridgeBio Pharma Inc. Check cash flow reinvestment rate of BridgeBio Pharma Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).